Patent details
EP3395836 Title: HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
Basic Information
- Publication number:
- EP3395836
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP181626581
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English Title of Invention:
- HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS
- French Title of Invention:
- ANTICORPS HUMAINS ANTI-PCSK9 POUR UTILISATION DANS DES PROCÉDÉS DE TRAITEMENT DE GROUPES DE SUJETS PARTICULIERS
- German Title of Invention:
- MENSCHLICHE ANTIKÖRPER GEGEN PSCK9 ZUR VERWENDUNG IN VERFAHREN ZUR BEHANDLUNG BESTIMMTER GRUPPEN VON PERSONEN
- SPC Number:
Dates
- Filing date:
- 27/01/2012
- Grant date:
- 28/04/2021
- EP Publication Date:
- 31/10/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/04/2021
- EP B1 Publication Date:
- 28/04/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/01/2022
- Expiration date:
- 27/01/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/04/2021
- Name:
- Sanofi Biotechnology
- Address:
- 54 rue La Boétie, 75008 Paris, France (FR)
Inventor
1
- Name:
- Bessac, Laurence
- Address:
- France (FR)
2
- Name:
- Hanotin, Corinne
- Address:
- France (FR)
3
- Name:
- CHAUDHARI, Umesh
- Address:
- United States (US)
Priority
1
- Priority Number:
- 11305088
- Priority Date:
- 28/01/2011
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 11305089
- Priority Date:
- 28/01/2011
- Priority Country:
- European Patent Office (EPO) (EP)
3
- Priority Number:
- 11305514
- Priority Date:
- 29/04/2011
- Priority Country:
- European Patent Office (EPO) (EP)
4
- Priority Number:
- 11305513
- Priority Date:
- 29/04/2011
- Priority Country:
- European Patent Office (EPO) (EP)
5
- Priority Number:
- 11306039
- Priority Date:
- 12/08/2011
- Priority Country:
- European Patent Office (EPO) (EP)
6
- Priority Number:
- 11306040
- Priority Date:
- 12/08/2011
- Priority Country:
- European Patent Office (EPO) (EP)
7
- Priority Number:
- 11306201
- Priority Date:
- 22/09/2011
- Priority Country:
- European Patent Office (EPO) (EP)
8
- Priority Number:
- 11306202
- Priority Date:
- 22/09/2011
- Priority Country:
- European Patent Office (EPO) (EP)
9
- Priority Number:
- 11306450
- Priority Date:
- 08/11/2011
- Priority Country:
- European Patent Office (EPO) (EP)
10
- Priority Number:
- 11306449
- Priority Date:
- 08/11/2011
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- C07K 16/40; A61K 39/395; A61K 45/06; A61J 1/05; A61K 31/215; A61K 31/366; A61K 31/404; A61K 31/435; A61K 31/47; A61K 31/505; C07K 14/47; A61K 39/00; A61P 3/00; A61P 3/06; A61P 5/00; A61P 7/00; A61P 9/00; A61P 9/10; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202117
- Publication date:
- 28/04/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202119
- Publication date:
- 12/05/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|